Charles River Laboratories | CRL - Net Income


Charles River Laboratories reported $-1.48M in Net Income for its fiscal quarter ending in June of 2026.





Net Income Change Date
Agilent USD 339M 34M Mar/2026
Align Technology USD 108.29M 4.48M Jun/2026
Bio-Rad Laboratories USD 371.4M 898.5M Jun/2026
Bruker USD -62.9M 66.4M Jun/2026
Cardinal Health USD 399M 68M Mar/2026
Charles River Laboratories USD -1.48M 13.36M Jun/2026
Cigna USD 1.66B 6M Jun/2026
Concord Medical Services Hldg CNY -65.68M 38.54M Dec/2025
CVS Health USD 2.98B 36M Jun/2026
Danaher USD 870M 159M Jun/2026
Dentsply International USD 37M 47M Jun/2026
Elevance Health USD 1.46B 301M Jun/2026
Humana USD 694M 492M Jun/2026
Illumina USD 207M 73M Jun/2026
Incyte USD 585.6M 282.27M Jun/2026
IQVIA Holdings USD 256M 18M Jun/2026
Laboratory Of America USD 298.7M 20.9M Jun/2026
Lakefront Biotherapeutics EUR 14.49M 767.65M Mar/2026
Lonza CHF 426M 119M Jun/2025
McKesson USD 614M 1.07B Jun/2026
Merck EUR 659M 340M Mar/2026
Mettler Toledo International USD 232.9M 63.44M Jun/2026
Novartis USD 3.26B 108M Jun/2026
Pfizer USD -248M 2.94B Jun/2026
Quest Diagnostics USD 320M 69M Jun/2026
Revvity USD 51.82M 11.1M Jun/2026
Thermo Fisher Scientific USD 1.74B 85M Jun/2026
United Therapeutics USD 333M 58.1M Jun/2026
UnitedHealth USD 5.48B 796M Jun/2026
Veradigm USD -59.82M 74.35M Dec/2022
Waters USD -136M 64M Jun/2026
West Pharmaceutical Services USD 154M 15.2M Jun/2026